Latest Insider Transactions at Pacira Bio Sciences, Inc. (PCRX)
This section provides a real-time view of insider transactions for Pacira Bio Sciences, Inc. (PCRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Pacira BioSciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Pacira BioSciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
David M Stack CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+14.92%
|
-
|
|
Jun 14
2023
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
6,467
-20.31%
|
$239,279
$37.03 P/Share
|
|
Jun 14
2023
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,950
+25.59%
|
-
|
|
Jun 14
2023
|
Gary W Pace Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+1.24%
|
-
|
|
Jun 14
2023
|
Charles A. Reinhart Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+17.43%
|
-
|
|
Jun 14
2023
|
Mark Froimson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+18.46%
|
-
|
|
Jun 14
2023
|
Daryl Gaugler Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+24.07%
|
-
|
|
Jun 14
2023
|
Paul J Hastings Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+17.49%
|
-
|
|
Jun 14
2023
|
Mark A. Kronenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+8.28%
|
-
|
|
Jun 14
2023
|
Laura Brege Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+13.55%
|
-
|
|
Jun 14
2023
|
Christopher Christie Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+25.23%
|
-
|
|
Jun 08
2023
|
Mark A. Kronenfeld Director |
SELL
Open market or private sale
|
Direct |
15,000
-45.6%
|
$555,000
$37.04 P/Share
|
|
Jun 08
2023
|
Mark A. Kronenfeld Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+31.32%
|
$435,000
$29.9 P/Share
|
|
Jun 07
2023
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,357
-6.1%
|
$50,209
$37.87 P/Share
|
|
Jun 07
2023
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,857
-4.3%
|
$68,709
$37.87 P/Share
|
|
Jun 07
2023
|
Charles A. Reinhart Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,371
-3.92%
|
$50,727
$37.87 P/Share
|
|
Jun 07
2023
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
616
-3.13%
|
$22,792
$37.87 P/Share
|
|
Jun 07
2023
|
Jonathan Slonin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
490
-1.33%
|
$18,130
$37.87 P/Share
|
|
Jun 07
2023
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,326
-3.35%
|
$197,062
$37.87 P/Share
|
|
Jun 07
2023
|
Dennis Mc Loughlin Chief Customer Officer |
SELL
Open market or private sale
|
Direct |
1,057
-2.7%
|
$39,109
$37.87 P/Share
|
|
Jun 07
2023
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
1,099
-3.62%
|
$40,663
$37.87 P/Share
|
|
Jun 07
2023
|
Ronald J. Ellis Jr. Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,162
-3.62%
|
$42,994
$37.87 P/Share
|
|
Jun 07
2023
|
Daryl Gaugler Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,047
-4.64%
|
$38,739
$37.87 P/Share
|
|
Jun 06
2023
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,301
-5.52%
|
$49,438
$38.99 P/Share
|
|
Jun 06
2023
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,779
-3.95%
|
$67,602
$38.99 P/Share
|
|
Jun 06
2023
|
Charles A. Reinhart Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,236
-3.41%
|
$46,968
$38.99 P/Share
|
|
Jun 06
2023
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
591
-2.92%
|
$22,458
$38.99 P/Share
|
|
Jun 06
2023
|
Jonathan Slonin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
471
-1.26%
|
$17,898
$38.99 P/Share
|
|
Jun 06
2023
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,058
-3.08%
|
$192,204
$38.99 P/Share
|
|
Jun 06
2023
|
Dennis Mc Loughlin Chief Customer Officer |
SELL
Open market or private sale
|
Direct |
1,014
-2.52%
|
$38,532
$38.99 P/Share
|
|
Jun 06
2023
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
4,521
-25.99%
|
$171,798
$38.55 P/Share
|
|
Jun 06
2023
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
1,054
-3.36%
|
$40,052
$38.99 P/Share
|
|
Jun 06
2023
|
Ronald J. Ellis Jr. Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,114
-3.36%
|
$42,332
$38.99 P/Share
|
|
Jun 06
2023
|
Daryl Gaugler Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,005
-4.26%
|
$38,190
$38.99 P/Share
|
|
Jun 05
2023
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
2,267
-11.53%
|
$86,146
$38.28 P/Share
|
|
Jun 05
2023
|
Daryl Gaugler Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-4.07%
|
$38,000
$38.74 P/Share
|
|
Jun 05
2023
|
Paul J Hastings Director |
SELL
Open market or private sale
|
Direct |
580
-8.08%
|
$22,040
$38.34 P/Share
|
|
Jun 05
2023
|
Laura Brege Director |
SELL
Open market or private sale
|
Direct |
600
-5.91%
|
$22,800
$38.74 P/Share
|
|
May 31
2023
|
Daryl Gaugler Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,500
-9.23%
|
$97,500
$39.08 P/Share
|
|
May 31
2023
|
Daryl Gaugler Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+8.51%
|
$85,000
$34.0 P/Share
|
|
May 15
2023
|
Paul J Hastings Director |
SELL
Open market or private sale
|
Direct |
7,000
-49.37%
|
$287,000
$41.85 P/Share
|
|
May 15
2023
|
Paul J Hastings Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+33.05%
|
$203,000
$29.9 P/Share
|
|
May 11
2023
|
Gary W Pace Director |
SELL
Open market or private sale
|
Direct |
5,015
-3.47%
|
$205,615
$41.78 P/Share
|
|
May 11
2023
|
Gary W Pace Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.61%
|
$203,000
$29.9 P/Share
|
|
Apr 03
2023
|
Laura Brege Director |
SELL
Open market or private sale
|
Direct |
7,000
-40.82%
|
$280,000
$40.72 P/Share
|
|
Apr 03
2023
|
Laura Brege Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+28.99%
|
$203,000
$29.9 P/Share
|
|
Jan 05
2023
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
546
-2.73%
|
$20,748
$38.31 P/Share
|
|
Jan 04
2023
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
158
-0.78%
|
$6,162
$39.09 P/Share
|
|
Oct 07
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
1,380
-4.21%
|
$80,040
$58.0 P/Share
|
|
Aug 03
2022
|
Jonathan Slonin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
308
-0.82%
|
$16,940
$55.7 P/Share
|